Proteomic approaches for the study of tissue specific effects of 3,5,3′-triiodo-L-thyronine and 3,5-diiodo-L-thyronine in conditions of altered energy metabolism

被引:10
作者
Silvestri, Elena [1 ]
Coppola, Maria [1 ]
Cioffi, Federica [1 ]
Goglia, Fernando [1 ]
机构
[1] Univ Sannio, Dipartimento Sci & Tecnol, I-82100 Benevento, Italy
来源
FRONTIERS IN PHYSIOLOGY | 2014年 / 5卷
关键词
iodothyronine; metabolism; proteomics; obesity; mitochondrion; THYROID-HORMONE RECEPTOR; INDUCED INSULIN-RESISTANCE; SKELETAL-MUSCLE; IN-VIVO; LIVER; EXPRESSION; GENES; RATS;
D O I
10.3389/fphys.2014.00491
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
In vertebrates and, specifically, in mammals, energy homeostasis is achieved by the integration of metabolic and neuroendocrine signals linked to one another in an intricate network hierarchically responding to the tight modulating action of hormones among which thyroid hormones (THs) play a central role. At the cellular level, 3,5,3'-triiodo-L-thyronine (T3) acts mainly by binding to specific nuclear receptors (TRs) but actually it is becoming more and more evident that some T3-actions are independent of TRs and that other iodothyronines, such as 3,5-diiodo-L-thyronine (T2), affect energy metabolism and adiposity. In the postgenomic era, clinical and basic biological researches are increasingly benefiting from the recently developed new omics approaches including, among the others, proteomics. Considering the recognized value of proteins as excellent targets in physiology, the functional and simultaneous analysis of the expression level and the cellular localization of multiple proteins can actually be considered fundamental in the understanding of complex mechanisms such as those involved in thyroid control of metabolism. Here, we will discuss new leads (i.e., target proteins and metabolic pathways) emerging in applying proteomics to the actions of T3 and T2 in conditions of altered energy metabolism in animal tissues having a central role in the control of energy balance.
引用
收藏
页数:5
相关论文
共 44 条
[1]  
Antonelli A, 2011, J BIOL REG HOMEOS AG, V25, P655
[2]   Mechanisms of thyroid hormone action [J].
Brent, Gregory A. .
JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (09) :3035-3043
[3]   Why Can Insulin Resistance Be a Natural Consequence of Thyroid Dysfunction? [J].
Brenta, Gabriela .
JOURNAL OF THYROID RESEARCH, 2011, 2011
[4]   Thyroid hormone analogues and derivatives: Actions in fatty liver [J].
Coppola, Maria ;
Glinni, Daniela ;
Moreno, Maria ;
Cioffi, Federica ;
Silvestri, Elena ;
Goglia, Fernando .
WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (03) :114-129
[5]   Adjunctive Input to the Nuclear Thyroid Hormone Receptor from the Cell Surface Receptor for the Hormone [J].
Davis, Paul J. ;
Lin, Hung-Yun ;
Tang, Heng-Yuan ;
Davis, Faith B. ;
Mousa, Shaker A. .
THYROID, 2013, 23 (12) :1503-1509
[6]   Nonthyrotoxic Prevention of Diet-Induced Insulin Resistance by 3,5-Diiodo-L-Thyronine in Rats [J].
de Lange, Pieter ;
Cioffi, Federica ;
Senese, Rosalba ;
Moreno, Maria ;
Lombardi, Assunta ;
Silvestri, Elena ;
De Matteis, Rita ;
Lionetti, Lilla ;
Mollica, Maria Pina ;
Goglia, Fernando ;
Lanni, Antonia .
DIABETES, 2011, 60 (11) :2730-2739
[7]   Proteomic Approaches to Analyze Protein Tyrosine Nitration [J].
Feeney, Maria B. ;
Schoeneich, Christian .
ANTIOXIDANTS & REDOX SIGNALING, 2013, 19 (11) :1247-1256
[8]   Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray [J].
Feng, X ;
Jiang, Y ;
Meltzer, P ;
Yen, PM .
MOLECULAR ENDOCRINOLOGY, 2000, 14 (07) :947-955
[9]   Biological effects of 3,5-diiodothyronine (T2) [J].
Goglia, F .
BIOCHEMISTRY-MOSCOW, 2005, 70 (02) :164-172
[10]   Thyroid Hormone Reduces Cholesterol via a Non-LDL Receptor-Mediated Pathway [J].
Goldberg, Ira J. ;
Huang, Li-Shin ;
Huggins, Lesley A. ;
Yu, Shuiqing ;
Nagareddy, Prabhakara R. ;
Scanlan, Thomas S. ;
Ehrenkranz, Joel R. .
ENDOCRINOLOGY, 2012, 153 (11) :5143-5149